# Prevalence, Antimicrobial Resistance Profiles, and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus Among School Children in Nha Trang, Central Vietnam

**Authors:** Stephen Anyona Omae, Shah Mohammad Monir, Hien-Anh Thi Nguyen, Kim-Mai Huynh, Natsuki Ariyoshi, Lien Thuy Le, Dat Thanh Le, Trieu Bao Nguyen, Hoang Huy Le, Luong Dinh Nguyen, Miyuki Tsuruoka, Hirono Otomaru, Erik Koehne, Michiko Toizumi, Duc-Anh Dang, Hung Thai Do, Lay-Myint Yoshida

PMC · DOI: 10.3390/pathogens15020238 · Pathogens · 2026-02-22

## TL;DR

This study examines MRSA prevalence and resistance among schoolchildren in Nha Trang, Vietnam, finding high rates of colonization and resistance to multiple antibiotics.

## Contribution

The study provides new insights into MRSA carriage and resistance patterns in Vietnamese schoolchildren, emphasizing the need for community surveillance.

## Key findings

- MRSA colonization was highest in primary school children at 48%.
- Most MRSA isolates showed resistance to trimethoprim-sulfamethoxazole, erythromycin, and clindamycin.
- SCCmec type IVa was the most common subtype, and ST45 was the dominant sequence type.

## Abstract

Staphylococcus aureus (S. aureus), especially Methicillin-resistant Staphylococcus aureus (MRSA), remains a major public health concern both in hospital and community settings. The MRSA carriage situation among schoolchildren in Vietnam is limited. A cross-sectional study was conducted in March 2023 to assess the prevalence, antimicrobial resistance patterns, and molecular characteristics of MRSA among schoolchildren in Nha Trang, Vietnam. Schoolchildren from grades 1 to 12 (ages 6–18 yrs) were enrolled. Background epidemiological data and nasal swabs were collected. Nasal samples were processed at the Pasteur Institute in Nha Trang, Vietnam, for S. aureus culture. Out of 1210 participants enrolled, S. aureus prevalence was 18.3% (222/1210), of which 41% (91/222) were MRSA. Primary school children showed the highest prevalence of MRSA colonization (48%), 32.8% in secondary, and 27.8% in high school. Among MRSA isolates, high levels of resistance were detected against trimethoprim-sulfamethoxazole (100%), erythromycin (68.2%) and clindamycin (45.1%). Multidrug resistance (MDR) occurred in 30% (27/90) of MRSA isolates. Staphylococcal cassette chromosome mec (SCCmec) subtype IVa was dominant (66.0%), followed by type IV (7.0%) and type V (6.0%). MLST data revealed genetic diversity whereby ST45 dominated, followed by ST546 and ST188. Continuous MRSA surveillance is essential to monitor emerging strains in the communities.

## Linked entities

- **Chemicals:** trimethoprim-sulfamethoxazole (PubChem CID 358641), erythromycin (PubChem CID 12560), clindamycin (PubChem CID 446598)
- **Species:** Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Genes:** Penicillin-binding Protein [NCBI Gene 28381262], glycerol kinase [NCBI Gene 28381140], triosephosphate isomerase [NCBI Gene 28381662], catalase [NCBI Gene 28381092], shikimate dehydrogenase [NCBI Gene 28380816], guanylate kinase [NCBI Gene 28381234], phosphate acetyltransferase [NCBI Gene 28379130]
- **Diseases:** febrile illness (MESH:D005334), pneumonia (MESH:D011014), SCCmec type IVa (MESH:D011023), asthma (MESH:D001249), MDR (MESH:D018088), injury to (MESH:D014947), pulmonary infections (MESH:D012141), skin and soft tissue infections (MESH:D018461), MRSA (MESH:D013203), sepsis (MESH:D018805), Infectious Diseases (MESH:D003141), osteomyelitis (MESH:D010019), endocarditis (MESH:D004696), congenital heart disease (MESH:D006330), infection (MESH:D007239)
- **Chemicals:** mecA (MESH:C046756), Methicillin (MESH:D008712), ERY (MESH:D004917), MFX (MESH:D000077266), GEN (MESH:D005839), VAN (MESH:D014640), LVX (MESH:D064704), Q/D (MESH:C062940), CLI (MESH:D002981), CIP (MESH:D002939), TGC (MESH:D000078304), MgCl2 (MESH:D015636), cefoxitin (MESH:D002440), azithromycin (MESH:D017963), Quinupristin (MESH:C113825), beta-lactam (MESH:D047090), Trimethoprim-Sulfamethoxazole (MESH:D015662), IPM (MESH:D015378), AMP (MESH:D000667), DAP (MESH:D017576), TMP (MESH:D013938), fluoroquinolones (MESH:D024841), LZD (MESH:D000069349), RIF (MESH:D012293), macrolide (MESH:D018942), penicillin (MESH:D010406), TCY (MESH:D013752), NI/F (MESH:D009582), ATCC 25923 (-), Dalfopristin (MESH:C113826)
- **Species:** Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280]
- **Cell lines:** ATCC 25923 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12943241/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943241/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12943241/full.md

---
Source: https://tomesphere.com/paper/PMC12943241